Metabolic activity of the subthalamic nucleus in a primate model of L-Dopa-unresponsive parkinsonism

Neurological Research

Volumn 32, Issue 10, 2010, Pages 1050-1053

  Fernagut, Pierre Olivier ^a   Barraud, Quentin ^a   Bezard, Erwan ^a   Ghorayeb, Imad ^a   Tison, Francois ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Basal ganglia; Cytochrome oxidase; Monkey; Multiple system atrophy; Parkinson; Subthalamic nucleus

Indexed keywords

CYTOCHROME C OXIDASE; LEVODOPA;

ARTICLE; CONTROLLED STUDY; FEMALE; HISTOCHEMISTRY; HUNTINGTON CHOREA; METABOLIC ACTIVATION; MONKEY; NONHUMAN; PARKINSONISM; STRIATONIGRAL DEGENERATION; SUBTHALAMIC NUCLEUS;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FEMALE; LEVODOPA; MACACA FASCICULARIS; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 77958195000     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164110X12807570509934     Document Type: Article

References (27)

1. Brouillet E, Conde F, Beal MF, Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 1999;59(5):427-68.
2. Meissner W, Prunier C, Guilloteau D, Chalon S, Gross CE, Bezard E. Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. Mol Neurobiol 2003;28(3):209-18.
3. Fernagut PO, Ghorayeb I, Diguet E, Tison F. In vivo models of multiple system atrophy. Mov Disord 2005;20 Suppl 12:S57-63.
4. Benabid AL. Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 2003;13(6):696-706.
5. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12(2):133-47.
6. Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy\-parkinsonism. Report of four cases. J Neurosurg 2003;98(4):882-87.
7. Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003;61(2):247-49.
8. Chou KL, Forman MS, Trojanowski JQ, Hurtig HI, Baltuch GH. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. J Neurosurg 2004;100(3):553-56.
9. Lezcano E, Gomez-Esteban JC, Zarranz JJ, Alcaraz R, Atarés B, Bilbao G, et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 2004;19(8): 973-77.
10. Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord 2007;22(15):2149-55.
11. Ghorayeb I, Fernagut PO, Aubert I, Bezard E, Poewe W, Wenning GK, et al. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Mov Disord 2000;15(3):531-36.
12. Ghorayeb I, Fernagut PO, Stefanova N, Wenning GK, Bioulac B, Tison F. Dystonia is predictive of subsequent altered dopaminer-gic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridinez3-nitropropionic acid model of striatonigral degeneration in monkeys. Neurosci Lett 2002;335(1): 34-38.
13. Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, et al. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 2001;21(17):6853-61.
14. Bezard E, Imbert C, Deloire X, Bioulac B, Gross CE. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey. Brain Res 1997;766(1-2):107-12.
15. Gonzalez-Lima F, Cada A. Quantitative histochemsitry of cytochrome oxidase activity. In: Gonzalez-Lima F, editor. Cytochrome oxidase in neuronal metabolism and Alzheimer's disease. New York: Plenum Press; 1998. p. 55-90.
16. Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, et al. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 2005;57(1):17-26.
17. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13(7):266-71.
18. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72(2):507-20.
19. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007;130(Pt 7):1834-46.
20. Pereira LC, Palter VN, Lang AE, Hutchison WD, Lozano AM, Dostrovsky JO. Neuronal activity in the globus pallidus of multiple system atrophy patients. Mov Disord 2004;19(12):1485-92.
21. Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989;12(3):94-101.
22. Vila M, Perier C, Feger J, Yelnik J, Faucheux B, Ruberg M, et al. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur J Neurosci 2000;12(1):337-44.
23. Hevner RF, Wong-Riley MT. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J Neurosci 1991;11(7):1942-58.
24. Meissner W, Guigoni C, Cirilli L, Garret M, Bioulac BH, Gross CE, et al. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglu-cose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease. Eur J Neurosci 2007;25(5):1492-500.
25. Hirsch EC, Perier C, Orieux G, François C, Féger J, Yelnik J, et al. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 2000;23(10 Suppl):S78-85.
26. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004;127(Pt 12):2657-71.
27. Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 2008;70(5):368-73.